Kopran Profit & Loss Annual

BSE: 524280 | NSE: KOPRAN | ISIN: INE082A01010 | Sector: Biotechnology & Drugs

283.05 +19.05 (7.22%)Updated : 14 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	620.96	571.05	546.61	505.70
Other Net	-1.61	-1.50	-1.52	-0.95
Diluted Weighted Average Shares	4.82	4.82	4.82	4.82
Depreciation/ Amortization	17.47	15.59	12.89	12.71
Operating Income	60.46	58.56	67.99	45.28
Net Income	25.73	38.55	50.96	27.23
Income Availableto Com Excl Extra Ord	25.73	38.55	50.96	27.23
Other Operating Expenses Total	3.66	4.07	3.35	4.36
Net Income Before Taxes	34.36	51.95	67.54	36.07
Net Income After Taxes	25.73	38.55	50.96	27.23
Income Availableto Com Incl Extra Ord	25.73	38.55	50.96	27.23
Costof Revenue Total	475.97	437.22	433.01	388.14
Gross Profit	205.46	192.39	181.58	162.85
Interest Inc( Exp) Net- Non- Op Total	-24.50	-5.11	1.08	-8.26
Unusual Expense( Income)	0.00	0.00	0.00	0.00
Diluted Net Income	25.73	38.55	50.96	27.23
DPS- Common Stock Primary Issue	3.00	3.00	3.00	3.00
Provisionfor Income Taxes	8.63	13.40	16.59	8.83
period Type	-	-	-	-
Net Income Before Extra Items	25.73	38.55	50.96	27.23
Total Revenue	681.42	629.60	614.59	550.99
period Length	12.00	12.00	12.00	12.00
Revenue	681.42	629.60	614.59	550.99
Selling/ General/ Admin Expenses Total	123.86	114.16	97.35	100.49
Diluted Normalized EPS	5.33	7.99	10.57	5.65
Diluted EPS Excluding Extra Ord Items	5.33	7.99	10.57	5.65
Gain( Loss)on Saleof Assets	-	-	0.00	0.00